EVISTA improves bone quality as measured by HRpQCT: IIT

Links shared publicly online about this topic.

1,061
total visits

EVISTA improves bone quality as measured by HRpQCT: IIT

Interim data from a prospective Investigator Initiated Trial presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the treatment and prevention of osteoporosis in postmenopausal women, improves bone quality as measured by the high-resolution peripheral quantitative computed tomography.

View full resource at news-medical.net

Tags: Bone, Osteoporosis, Osteoporosis Medication, Women's Health, Evista, Daiichi Sankyo